English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Jamie Barrand | Dec 2, 2015

AAFP responds to CMS feedback request for alternative payment models

+ Technology/Innovation
Jamie Barrand | Dec 2, 2015

Bristol-Myers Squibb to present data at 57th Annual Meeting & Exposition of the American Society of Hematology

+ Technology/Innovation
Jamie Barrand | Dec 2, 2015

Lawmakers introduce 'REPEAL' HIV Discrimination Act

+ Technology/Innovation
Jamie Barrand | Dec 2, 2015

African Americans with depression more likely to suffer strokes, coronary disease, AHA study shows

+ Regulatory
Jamie Barrand | Dec 1, 2015

Social barriers keep heart-failure patients from getting exercise they need, AMA study finds

+ Technology/Innovation
Jamie Barrand | Dec 1, 2015

Synthetic Biologics releases study results for SYN-004

+ Community
Jamie Barrand | Dec 1, 2015

AbbVie launches hyperthyroidism education program

+ Technology/Innovation
Jamie Barrand | Dec 1, 2015

Study looks at link between pollution, heart disease in diabetic women

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 487
  • 488
  • 489
  • 490
  • 491
  • 492
  • 493
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily